Provided by Tiger Trade Technology Pte. Ltd.

HBM HOLDINGS-B

14.050
+1.35010.63%
Volume:15.47M
Turnover:214.55M
Market Cap:12.21B
PE:127.73
High:14.230
Open:12.910
Low:12.700
Close:12.700
52wk High:17.070
52wk Low:9.460
Shares:869.00M
HK Float Shares:869.00M
Volume Ratio:1.61
T/O Rate:1.78%
Dividend:- -
Dividend Rate:- -
EPS(LYR):0.110
ROE:23.97%
ROA:10.88%
PB:3.72
PE(LYR):127.73
PS:8.69

Loading ...

Morning Market Recap: Hong Kong Stocks Edge Higher, AI Drug Development Sector Surges

Stock News
·
Sep 18

HK Stocks in Focus: Biopharma Sector Surges as 10 Ministries Unveil 15th Five-Year Plan; Analysts See Potential 'Claude Moment' for Industry

Stock News
·
Sep 18

Movement Alert|HBM HOLDINGS-B Rises 5.2% in Regular Trading, Subsidiary Develops Worlds First Fully Human Heavy-Chain Antibody Language Model

Market Focus
·
Sep 18

HBM Climbs on Development of AI Biology Foundation Model

Reuters
·
Sep 17

HBM Holdings: Nona Biosciences Launches First Language Model Tailored to Fully Human Heavy-Chain-Only Antibodies

Bulletin Express
·
Sep 16

Hbm Holdings - Hcablm Built on 31.8 Mln Fully Human Hcab Sequences from 73 Immunized Hcab Mice

THOMSON REUTERS
·
Sep 16

Hbm Holdings - Nona Biosciences Develops Hcablm, World's First Language Model for Fully Human Heavy-Chain-Only Antibodies

THOMSON REUTERS
·
Sep 16

Movement Alert|HBM HOLDINGS-B Falls 5.34% in Regular Trading, Interim Profit and Cash Flow Under Pressure Amid Biotech Sector Weakness

Market Focus
·
Sep 16

Movement Alert|HBM HOLDINGS-B Falls 5.31% in Regular Trading, Biotech Sector Weakness Compounds Interim Profit and Cash Flow Pressure

Market Focus
·
Sep 15

Movement Alert|HBM HOLDINGS-B Falls 5.21% in Regular Trading, Biotech Sector Weakness Compounded by Interim Profit Decline

Market Focus
·
Sep 11

HBM Holdings Delivers H1 2026 Profit of USD 64.85 Million on Double-Digit Revenue Growth and Pipeline Advances

Bulletin Express
·
Sep 10

HBM Holdings FY26 H1 Profit Falls 11.16% to US$ 64.85 Million; Revenue Rises 20.9% to US$ 122.49 Million

Reuters
·
Sep 10

Hong Kong Stock Market Highlights: JXR Advances Female Health Translational Medicine Platform

Stock News
·
Sep 10

Hbm Holdings Says Solstice Oncology Launches Series a Financing Round

Reuters
·
Sep 09

HBM Holdings Highlights Partner Solstice Oncology’s USD 225.00 Million Series A Round

Bulletin Express
·
Sep 09

HBM Holdings' Strategic Partner Secures $225M Series A, Launches Operations

Stock News
·
Sep 09

HBM Partner Solstice Oncology Launches Phase 2 Trial of Porustobart in Neoadjuvant MSS Stage II-III Colon Cancer

Reuters
·
Sep 09

Harbour Biomed Partner, Solstice Oncology, Announces $225 Million Series a Financing to Advance Porustobart, a Neoadjuvant Immuno-Oncology Therapy

THOMSON REUTERS
·
Sep 09

Hbm Holdings - Solstice Oncology Launches $225 Mln Series a Financing Round

THOMSON REUTERS
·
Sep 09

HK-Listed HBM Climbs on Initiating Next Phase of Asthma Drug Study

Reuters
·
Sep 09